Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 783
Filter
1.
Arq. ciências saúde UNIPAR ; 27(1): 149-160, Jan-Abr. 2023.
Article in Portuguese | LILACS | ID: biblio-1414818

ABSTRACT

O objetivo deste trabalho foi analisar os efeitos do distanciamento social à saúde psicossocial da pessoa idosa no período da pandemia da COVID-19. Metodologia: Estudo revisão integrativa, realizado entre abril e Setembro de 2022, documentos dispo- nível como artigos científicos; ano de publicação 2020 a 2022. Os critérios de exclusão foram artigos de revisão, arquivos do tipo dissertação e teses. A pesquisa incluiu 47 do- cumentos; posteriormente foi realizada leitura crítica e reflexiva dos assim, estabeleceu- se a amostra de 11 artigos. Resultados e Discussão: Mediante todas as medidas tomadas para conter a pandemia, o distanciamento social é a estratégia até então mais eficiente para evitar a disseminação do vírus. Entretanto, as evidências mostram que o mesmo pode trazer prejuízos de natureza psicológica e psicossomática à população, principalmente à população idosa, que é um dos grupos de risco para contágio da doença. Além disso, pode provocar hábitos como o sedentarismo e inatividade física, condições que também são atreladas ao desenvolvimento de doenças físicas, mentais e, consequentemente, ao risco de morte em populações vulneráveis. Conclusão: Trata-se de um fenômeno social com- plexo e que exige atenção das entidades prestadoras de serviço à comunidade idosa, assim como os gestores e familiares. Desse modo, as linhas de cuidado devem se basear nas respostas em rede, que realizam esforços intersetoriais que envolvem políticas públicas de saúde, apoio do estado, assistência social, seguridade e justiça em ação das proteções de direitos, instituídos no Estatuto do Idoso.


The objective of this work was to analyze the effects of social distancing on the psychosocial health of the elderly during the COVID-19 pandemic. Methodology: Integrative review study, carried out between April and September 2022, documents available as scientific articles; year of publication 2020 to 2022. Exclusion criteria were review articles, dissertation and theses type files. The research included 47 documents; later, a critical and reflective reading of the articles was carried out, thus, a sample of 11 articles was established. Results and Discussion: Through all the measures taken to contain the pandemic, social distancing is the most efficient strategy so far to prevent the spread of the virus. However, evidence shows that it can bring psychological and psychosomatic damage to the population, especially the elderly population, which is one of the risk groups for contagion of the disease. In addition, it can cause habits such as physical inactivity and physical inactivity, conditions that are also linked to the development of physical and mental illnesses and, consequently, to the risk of death in vulnerable populations. Conclusion: It is a complex social phenomenon that requires attention from entities providing services to the elderly community, as well as managers and family members. In this way, the lines of care must be based on network responses, which carry out intersectoral efforts that involve public health policies, state support, social assistance, security and justice in action of the protections of rights, established in the Statute of the Elderly.


El objetivo de este trabajo fue analizar los efectos del distanciamiento social en la salud psicosocial de los ancianos durante la pandemia de COVID-19. Metodología: Estudio de revisión integradora, realizado entre abril y septiembre de 2022, documentos disponibles como artículos científicos; año de publicación 2020 a 2022. Los criterios de exclusión fueron artículos de revisión, archivos tipo disertación y tesis. La investigación incluyó 47 documentos; posteriormente, se realizó una lectura crítica y reflexiva de los artículos, así, se estableció una muestra de 11 artículos. Resultados y Discusión: A través de todas las medidas tomadas para contener la pandemia, el distanciamiento social es la estrategia más eficiente hasta el momento para prevenir la propagación del virus. Sin em- bargo, la evidencia muestra que puede traer daños psicológicos y psicosomáticos a la población, especialmente a la población anciana, que es uno de los grupos de riesgo de contagio de la enfermedad. Además, puede provocar hábitos como la inactividad física y el sedentarismo, condiciones que también están relacionadas con el desarrollo de enfer- medades físicas y mentales y, en consecuencia, con el riesgo de muerte en poblaciones vulnerables. Conclusiones: Se trata de un fenómeno social complejo que requiere atención por parte de las entidades prestadoras de servicios a la comunidad de adultos mayores, así como de los gestores y familiares. De esta forma, las líneas de atención deben basarse en respuestas en red, que realicen esfuerzos intersectoriales que involucren políticas públicas de salud, apoyo estatal, asistencia social, seguridad y justicia en acción de las protecciones de derechos, establecidas en el Estatuto del Anciano.


Subject(s)
Aged/physiology , Pandemics/prevention & control , Psychosocial Support Systems , Physical Distancing , Review Literature as Topic , Health of the Elderly , Vulnerable Populations/psychology , COVID-19/psychology
2.
Chinese Journal of Epidemiology ; (12): 689-693, 2023.
Article in Chinese | WPRIM | ID: wpr-985548

ABSTRACT

A crucial lesson gained through the pandemic preparedness and response to COVID-19 is that all measures for epidemic control must be law-based. The legal system is related not only to public health emergency management per se but also to all aspects of the institutional supporting system throughout the lifecycle. Based on the lifecycle emergency management model, this article analyses the problems of the current legal system and the potential solutions. It is suggested that the lifecycle emergency management model shall be followed to establish a more comprehensive public health legal system and to gather the intelligence and consensus of experts with different expertise, including epidemiologists, sociologists, economists, jurist and others, which will collaboratively promote the science-based legislation in the field of epidemic preparedness and response for the establishment of a comprehensive legal system for public health emergency management and with Chinese characteristics.


Subject(s)
Humans , China , Pandemics/prevention & control , Public Health , Emergencies , Disaster Planning
3.
Article in Chinese | WPRIM | ID: wpr-985519

ABSTRACT

Ongoing global pandemic of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has promoted the unprecedented rapid development and large-scale rolling out of different platform-based COVID-19 vaccines worldwide. How to effectively respond to the expected scale increasing adverse events after vaccination campaign of COVID-19 vaccines is a common problem faced by the world. A lot of countries and regions around the world have arranged in advance at different levels, optimizing the original vaccine safety monitoring system from the perspectives of strengthening the foundation and capabilities, promoting internal and external cooperation, upgrading methods, as well as improving transparency and public communication, which has ensured the good and efficient operation of the system and can provide reference for the construction of relevant fields in China.


Subject(s)
Humans , COVID-19/prevention & control , COVID-19 Vaccines , Pandemics/prevention & control , SARS-CoV-2 , Viral Vaccines/adverse effects
4.
Article in Chinese | WPRIM | ID: wpr-985477

ABSTRACT

During the global efforts to prevent and control the COVID-19 pandemic, extensive research and development of SARS-CoV-2 vaccines using various technical approaches have taken place. Among these, vaccines based on adenovirus vector have gained substantial knowledge and experience in effectively combating potential emerging infectious diseases, while also providing novel ideas and methodologies for vaccine research and development (R&D). This comprehensive review focuses on the adenovirus vector technology platform in vaccine R&D, emphasizing the importance of mucosal immunity induced by adenoviral vector-based vaccine for COVID-19 prevention. Furthermore, it analyzes the key technical challenges and obstacles encountered in the development of vaccines based on the adenovirus vector technology platform, with the aim of providing valuable insights and references for researchers and professionals in related fields.


Subject(s)
Humans , COVID-19 Vaccines , Pandemics/prevention & control , COVID-19/prevention & control , SARS-CoV-2/genetics , Viral Vaccines/genetics , Adenoviridae/genetics , Technology
5.
Article in English | WPRIM | ID: wpr-971191

ABSTRACT

BACKGROUND@#Healthcare workers (HCWs) employed personal protective equipment (PPE) during the COVID-19 pandemic, crucial to protecting themselves from infection. To highlight the efficacy of PPE in preventing environmental infection among HCWs, a systematic review was conducted in line with PRISMA guidance.@*METHODS@#A search of the PubMed and Web of Science databases was conducted from January 2019 to April 2021 using pre-defined search terms. Articles were screened by three researchers. The approved papers were read in full and included in this review if relevance was mutually agreed upon. Data were extracted by study design and types of PPEs.@*RESULTS@#47 of 108 identified studies met the inclusion criteria, with seven reviews and meta-analyses, seven cohort, nine case-control, fifteen cross-sectional studies, four before and after, four case series, and one modeling studies. Wearing PPE offered COVID-19 protection in HCWs but required adequate training. Wearing surgical masks provided improved protection over cloth masks, while the benefit of powered air-purifying respirators is less clear, as are individual gowns, gloves, and/or face shields.@*CONCLUSIONS@#Wearing PPE, especially facial masks, is necessary among HCWs, while training in proper use of PPE is also important to prevent COVID-19 infection.


Subject(s)
Humans , COVID-19/prevention & control , Pandemics/prevention & control , Cross-Sectional Studies , Personal Protective Equipment , Health Personnel
6.
Chinese Journal of Lung Cancer ; (12): 148-150, 2023.
Article in Chinese | WPRIM | ID: wpr-971171

ABSTRACT

In recent years, the corona virus disease 2019 (COVID-19) pandemic has had a huge impact on the global medical, political and economic fields. Since the beginning of the COVID-19 epidemic, our understanding of the impact of COVID-19 has grown exponentially. Recently, the COVID-19 epidemic has changed rapidly in China, and there has been controversy over how to carry out surgical operations for patients with lung neoplastic lesions. Some studies have shown that lung cancer patients undergoing surgery are more likely to experience respiratory failure and perioperative death after contracting COVID-19 than the general population, however, delays in cancer treatment are also associated with increased mortality among these patients. In particular, the novel coronavirus Omikron variant has a higher transmissibility and may escape the immunity obtained through the previous novel coronavirus infection and vaccination. In order to minimize the risk of novel coronavirus infection in surgical patients, it is necessary to develop new treatment guidelines, expert consensus and preventive measures. However, the current rapid change of the epidemic situation has led to insufficient time and evidence to develop guidelines and consensus. Therefore, thoracic surgeons need to evaluate specific patient populations at higher risk of severe complications before surgery and weigh the benefit of surgical treatment against the risk of novel coronavirus infection. We try to give some recommendations on lung surgery during the current domestic epidemic situation based on the guidelines and consensus of oncology and thoracic surgery organizations in different regions on lung surgery.
.


Subject(s)
Humans , Lung Neoplasms/complications , COVID-19 , SARS-CoV-2 , Multiple Pulmonary Nodules , Pandemics/prevention & control , Lung
7.
Article in Chinese | WPRIM | ID: wpr-971031

ABSTRACT

Since the global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020, the virus has been evolving through mutations to acquire enhanced infectivity but reduced virulence. With a wide vaccination coverage among Chinese population, China is entering a new stage of SARS-CoV-2 infection control. The Working Group for the Prevention and Control of Neonatal SARS-CoV-2 Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics released the first and second editions of perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection in January and March 2020, respectively. In order to follow up new prevention and control needs, it is necessary to update the management plan to better guide clinical practice. Therefore, the Working Group formulated the 3rd-edition plan.


Subject(s)
Pregnancy , Infant, Newborn , Female , Humans , Child , COVID-19/epidemiology , SARS-CoV-2 , Pandemics/prevention & control , China/epidemiology , Virulence
8.
Frontiers of Medicine ; (4): 562-575, 2023.
Article in English | WPRIM | ID: wpr-982577

ABSTRACT

The Omicron family of SARS-CoV-2 variants are currently driving the COVID-19 pandemic. Here we analyzed the clinical laboratory test results of 9911 Omicron BA.2.2 sublineages-infected symptomatic patients without earlier infection histories during a SARS-CoV-2 outbreak in Shanghai in spring 2022. Compared to an earlier patient cohort infected by SARS-CoV-2 prototype strains in 2020, BA.2.2 infection led to distinct fluctuations of pathophysiological markers in the peripheral blood. In particular, severe/critical cases of COVID-19 post BA.2.2 infection were associated with less pro-inflammatory macrophage activation and stronger interferon alpha response in the bronchoalveolar microenvironment. Importantly, the abnormal biomarkers were significantly subdued in individuals who had been immunized by 2 or 3 doses of SARS-CoV-2 prototype-inactivated vaccines, supporting the estimation of an overall 96.02% of protection rate against severe/critical disease in the 4854 cases in our BA.2.2 patient cohort with traceable vaccination records. Furthermore, even though age was a critical risk factor of the severity of COVID-19 post BA.2.2 infection, vaccination-elicited protection against severe/critical COVID-19 reached 90.15% in patients aged ≽ 60 years old. Together, our study delineates the pathophysiological features of Omicron BA.2.2 sublineages and demonstrates significant protection conferred by prior prototype-based inactivated vaccines.


Subject(s)
Humans , Aged , Middle Aged , COVID-19/prevention & control , SARS-CoV-2 , Pandemics/prevention & control , China/epidemiology , Disease Outbreaks/prevention & control , Vaccination
9.
J. oral res. (Impresa) ; 11(5): 1-9, nov. 23, 2022. ilus
Article in English | LILACS | ID: biblio-1435331

ABSTRACT

Introduction: Chlorine, ethyl alcohol, and quaternary ammonium are disinfectants with antiviral activity against SARS-Cov2. However, there are no previous reports of their use and handling for cleaning and disinfection in dental offices. Objetive: To determine the use and management of disinfectants in critical and non-critical areas used by dentists in San Luis Potosí, Mexico, during the COVID-19 pandemic. Material and Methods: A validated cross-sectional survey was applied online to 100 dentists in San Luis Potosí between February and June 2021. Participants were informed about the handling of personal data according to the standard DOF regulations (DOF 07-05-2010). Results: A total of 100 dentists were included in the study, 63% female and 37% male, with a mean age of 26 years. The most widely used disinfectants during the pandemic in critical areas were Lysol® and 0.1% sodium hypochlorite in non-critical areas. Eighty-five percent of dentists know the adverse effects of inappropriate use of disinfectants, 72% did not have any sign or symptom associated with the use of disinfectants. The most used protection barrier was gloves (97%). Sixty-seven per cent of dentists disposed of disinfectant waste down the drain. Conclusion: Sodium hypochlorite and quaternary ammonium compounds and/or ethanol are used to clean non-critical and critical areas in dental offices. However, appropriate measures for their management are not adopted. It is necessary to implement educational strategies to improve the use and management of disinfectants in dental practice.


Introducción: Cloro, alcohol etílico y amonio cuaternario son desinfectantes que muestran actividad antiviral contra el SARS-Cov2, sin embargo, no existen reportes previos de su uso y manejo para la limpieza y desinfección en clínicas dentales. Objetivo: Determinar el uso y manejo de los desinfectantes en áreas críticas y no críticas empleados por los odontólogos en San Luis Potosí durante la COVID-19. Material y Métodos: Encuesta transversal validada y aplicada on-line a 100 odontólogos de San Luis Potosí durante febrero-junio 2021. Se informó a los participantes sobre el manejo de datos personales de acuerdo a la norma (DOF 05-07-2010). Resultados: Se incluyeron un total de 100 odontólogos, 63% del sexo femenino y 37% del sexo masculino, con una edad promedio de 26 años. Los desinfectantes más utilizados durante la pandemia en las áreas críticas fueron el Lysol® y el hipoclorito de sodio al 0.1% en áreas no críticas. El 85% de los odontólogos conocen los efectos adversos del uso inadecuado de los desinfectantes, 72% no tuvieron algún signo o síntoma asociado al uso de desinfectantes. La barrera de protección más utilizada fueron los guantes (97%). El 67% de los odontólogos eliminó los desechos de desinfectantes por la coladera. Conclusión: Para la limpieza de las áreas no críticas y críticas en las clínicas dentales se utilizan el hipoclorito de Sodio y compuestos de amonio cuaternario y/o etanol, sin embargo, no se utilizan las medidas adecuadas para su manejo. Es necesario implementar estrategias educativas para mejorar el uso y manejo de desinfectantes en la práctica dental.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Young Adult , Infection Control/methods , Dentists , Disinfectants , Pandemics/prevention & control , COVID-19/prevention & control , Disinfection , Cross Infection/prevention & control , Cross-Sectional Studies , Surveys and Questionnaires , Disinfectants/adverse effects , Mexico/epidemiology
10.
Arq. ciências saúde UNIPAR ; 26(3): 1149-1162, set-dez. 2022.
Article in Portuguese | LILACS | ID: biblio-1414432

ABSTRACT

A depressão é uma doença grave que atinge a população em geral, estudos epidemiológicos estimam que a prevalência da depressão ao longo da vida no Brasil está em torno de 15,5%. Os fatores que desencadeiam o aparecimento da depressão incluem fatores sociais, psicológicos, biológicos e também fatores externos específicos como eventos estressantes, solidão, consumo de álcool e drogas, doenças crônicas e dar á luz (depressão pós-parto). O objetivo da presente pesquisa consistiu em realizar uma revisão bibliográfica sobre as principais plantas medicinais com ação antidepressiva. A ansiedade vem se tornando um dos principais problemas da atualidade, sendo intensificada pela pandemia causada pelo coronavírus, onde constatou-se que durante o pico da pandemia onde os casos confirmados de COVID-19 no Brasil ascenderam de 45.757 para 330.890, e as mortes, de 2.906 para 21.048, o sentimento de tristeza/depressão atingiu 40% dos adultos brasileiros. Os sintomas de depressão podem ser amenizados quando a disponibilidade sináptica de monoaminas são aumentadas, e esse aumento pode ocorrer através da diminuição da metabolização desses neurotransmissores. Neste sentido, busca-se através da farmacoterapia a utilização de antidepressivos que disponibilizem as monoaminas na fenda sináptica. A escolha do fármaco é feita com base nos sintomas da depressão e na boa resposta a uma determinada classe de antidepressivos. Em fevereiro de 2009 o Ministério da saúde lançou a Relação Nacional de Plantas Medicinais de Interesse ao SUS (RENISUS), contendo 71 espécies vegetais que são distribuídas de forma in natura nas unidades básicas de saúde (UBS). Destas, somente três espécies apresentam efeito antidepressivo e ansiolítico comprovados na literatura sendo Matricharia chamomilla, Erytrinum mulungu e a Passiflora incarnata que também fazem parte da RENISUS. Além destas, outras espécies como a Melissa officinalis, Lippia alba, Valeriana officinalis e Piper methysticum são utilizadas pela população para tratar ansiedade, insônia e depressão, sugerindo desta forma que estas espécies sejam incluídas na RENISUS.


Depression is a serious disease that affects the general population, epidemiological studies estimate that the prevalence of depression throughout life in Brazil is around 15.5%. The factors that trigger the onset of depression include social, psychological, biological and also specific external factors such as stressful events, loneliness, alcohol and drug consumption, chronic diseases and giving birth (postpartum depression). The objective of the present research was to carry out a literature review on the main medicinal plants with antidepressant action. Anxiety has become one of the main problems of today, being intensified by the pandemic caused by the coronavirus, where it was found that during the peak of the pandemic where confirmed cases of COVID-19 in Brazil rose from 45,757 to 330,890, and deaths, from 2,906 to 21,048, the feeling of sadness/depression reached 40% of Brazilian adults. Symptoms of depression can be alleviated when synaptic availability of monoamines is increased, and this increase can occur through decreased metabolization of these neurotransmitters. In this sense, the use of antidepressants that make monoamines available in the synaptic cleft is sought through pharmacotherapy. The choice of drug is based on symptoms of depression and good response to a particular class of antidepressants. In February 2009, the Ministry of Health launched the National List of Medicinal Plants of Interest to the SUS (RENISUS), containing 71 plant species that are distributed in natura form in basic health units (UBS). Of these, only three species have antidepressant and anxiolytic effects proven in the literature, being Matricharia chamomilla, Erytrinum mulungu and Passiflora incarnata, which are also part of RENISUS. In addition to these, other species such as Melissa officinalis, Lippia alba, Valeriana officinalis and Piper methysticum are used by the population to treat anxiety, insomnia and depression, thus suggesting that these species are included in RENISUS.


Los estudios epidemiológicos estiman que la prevalencia de la depresión a lo largo de la vida en Brasil es de alrededor del 15,5%. Los factores que desencadenan la aparición de la depresión son sociales, psicológicos, biológicos y también factores externos específicos, como los acontecimientos estresantes, la soledad, el consumo de alcohol y drogas, las enfermedades crónicas y el parto (depresión posparto). El objetivo de esta investigación fue realizar una revisión bibliográfica sobre las principales plantas medicinales con acción antidepresiva. La ansiedad se ha convertido en uno de los principales problemas de la actualidad, intensificándose por la pandemia causada por el coronavirus, donde se encontró que durante el pico de la pandemia donde los casos confirmados de COVID-19 en Brasil aumentaron de 45.757 a 330.890, y las muertes, de 2.906 a 21.048, el sentimiento de tristeza/depresión alcanzó el 40% de los adultos brasileños. Los síntomas de la depresión pueden aliviarse cuando se aumenta la disponibilidad sináptica de las monoaminas, y este aumento puede producirse mediante una disminución de la metabolización de estos neurotransmisores. En este sentido, se busca a través de la farmacoterapia el uso de antidepresivos que hagan disponibles las monoaminas en la hendidura sináptica. La elección del fármaco se hace en función de los síntomas de la depresión y de la buena respuesta a una clase concreta de antidepresivos. En febrero de 2009, el Ministerio de Salud lanzó la Lista Nacional de Plantas Medicinales de Interés para el SUS (RENISUS), que contiene 71 especies de plantas que se distribuyen in natura en unidades básicas de salud (UBS). De ellas, sólo tres especies tienen efectos antidepresivos y ansiolíticos probados en la literatura: Matricharia chamomilla, Erytrinum mulungu y Passiflora incarnata, que también forman parte del RENISUS. Además de éstas, otras especies como Melissa officinalis, Lippia alba, Valeriana officinalis y Piper methysticum son utilizadas por la población para tratar la ansiedad, el insomnio y la depresión, lo que sugiere que estas especies se incluyan en el RENISUS.


Subject(s)
Plants, Medicinal/drug effects , Unified Health System , Central Nervous System/drug effects , Anxiety/drug therapy , Anti-Anxiety Agents/therapeutic use , Valerian/drug effects , Pharmaceutical Preparations , Kava/drug effects , Passiflora/drug effects , Matricaria/drug effects , Melissa/drug effects , Lippia/drug effects , Depression/drug therapy , Drug Therapy , Emotions/drug effects , Erythrina/drug effects , Pandemics/prevention & control , Antidepressive Agents/therapeutic use
11.
Arq. ciências saúde UNIPAR ; 26(3): 1191-1201, set-dez. 2022.
Article in Portuguese | LILACS | ID: biblio-1414435

ABSTRACT

A doença do coronavírus 2019 (COVID-19) é uma doença infecciosa que atinge o sistema respiratório humano. Para diminuir o risco da contaminação, foi determinado o isolamento social, mas com as pessoas nas residências, os efeitos nos hábitos alimentares podem ocorrer. Desta forma, o objetivo deste trabalho foi realizar uma pesquisa sobre o efeito da pandemia COVID-19 nos hábitos alimentares da população. Trata-se de um estudo transversal realizado no Brasil por meio de um questionário online que refere às características sociodemográficas e às mudanças nos estilos de vida, conhecimento sobre segurança dos alimentos, hábitos alimentares e o efeito da pandemia COVID-19. A pesquisa resultou em um total de 120 pessoas para a comparação dos hábitos alimentares antes e durante a pandemia COVID-19. Dos participantes, 71,1% das pessoas aumentaram o preparo das suas próprias refeições em sua residência durante a pandemia. E em relação a frequência do consumo em restaurantes, 59,7% dos entrevistados não consumiam em restaurantes antes e durante a pandemia. Em relação à frequência do consumo de alimentos industrializados como biscoito e pães, o consumo aumentou diariamente para 38,6% durante a pandemia. A partir desta comparação pode se observar que os hábitos alimentares da maioria da população avaliada sofreram mudanças, alguns de aspecto positivo e outros negativos. Conclui-se que houve mudanças nos hábitos alimentares da população durante a pandemia, sendo de maior aumento o consumo de alimentos industrializados e refeições preparadas em suas próprias residências.


Coronavirus disease 2019 (COVID-19) is an infectious disease that affects the human respiratory system. To reduce the risk of contamination, social isolation was determined, but with people in residences, the effects on eating habits can occur. Thus, the objective of this work was to carry out research on the effect of the COVID-19 pandemic on the population's eating habits. This is a cross-sectional study carried out in Brazil through an online questionnaire that refers to sociodemographic characteristics and changes in lifestyles, knowledge about food safety, eating habits and the effect of the COVID-19 pandemic. The survey resulted in a total of 120 people to compare eating habits before and during the COVID-19 pandemic. Of the participants, 71.1% of people increased the preparation of their own meals in their homes during the pandemic. And regarding the frequency of consumption in restaurants, 59.7% of respondents did not consume in restaurants before and during the pandemic. Regarding the frequency of consumption of processed foods such as biscuits and bread, the daily consumption increased to 38.6% during the pandemic. From this comparison, it can be seen that the eating habits of the majority of the population assessed underwent changes, some positive and some negative. It is concluded that there were changes in the population's eating habits during the pandemic, with a greater increase in the consumption of processed foods and meals prepared in their own homes.


El coronavirus 2019 (COVID-19) es una enfermedad infecciosa que afecta al sistema respiratorio humano. Para reducir el riesgo de contaminación, se determinó el aislamiento social, pero con personas en las residencias, pueden producirse efectos en los hábitos alimentarios. Así, el objetivo de este trabajo fue realizar una investigación sobre el efecto de la pandemia de COVID-19 en los hábitos alimentarios de la población. Se trata de un estudio transversal realizado en Brasil mediante un cuestionario online referido a las características sociodemográficas y los cambios en los estilos de vida, los conocimientos sobre seguridad alimentaria, los hábitos alimentarios y el efecto de la pandemia de COVID-19. La encuesta dio como resultado un total de 120 personas para la comparación de los hábitos alimentarios antes y durante la pandemia de COVID-19. De los participantes, el 71,1% aumentó la preparación de sus propias comidas en su residencia durante la pandemia. Y en cuanto a la frecuencia de consumo en restaurantes, el 59,7% de los encuestados no consumía en restaurantes antes y durante la pandemia. En cuanto a la frecuencia de consumo de alimentos procesados, como galletas y panes, el consumo aumentó diariamente hasta el 38,6% durante la pandemia. De esta comparación se puede observar que los hábitos alimentarios de la mayoría de la población evaluada sufrieron cambios, algunos positivos y otros negativos. Se concluye que hubo cambios en los hábitos alimentarios de la población durante la pandemia, siendo de mayor incremento el consumo de alimentos procesados y comidas preparadas en sus propios hogares.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Feeding Behavior , Pandemics/prevention & control , Cross-Sectional Studies/methods , Diet, Healthy , Food Supply , COVID-19/prevention & control , Sociodemographic Factors , Life Style
12.
Arq. ciências saúde UNIPAR ; 26(3): 1376-1397, set-dez. 2022.
Article in English | LILACS | ID: biblio-1414509

ABSTRACT

In December 2019, a new coronavirus originating from the city of Wuhan in China started an epidemic that brought many countries into chaos and despair. SARS-CoV-2, as identified, gave rise to the severe acute respiratory syndrome called COVID-19. Its transmission happens through droplets of saliva, hand or contaminated surfaces. Since its discovery, COVID-19 has led many to death, therefore, researchers from around the world have joined efforts to develop strategies to contain the virus. In this race, drugs such as Chloroquine and Hydroxychloroquine have become possible options for showing an antiviral effect, however, studies contest their efficiency, generating uncertainties. Therefore, other alternatives have been investigated in this context, and the study of medicinal plants has been the target of research for the treatment of COVID-19 in search of bioactive natural products that can exert an antiviral action. The study aimed to analyze the published literature on COVID-19 (SARS-CoV-2) and its relationship with medicinal plants. Bibliographical survey. So far, no specific treatment against the disease has been found, only supportive, with drugs that aim to improve the individual's immune system and ensure that the virus does not replicate, for example, there are options such as chloroquine, hydroxychloroquine, remdesivir and convalescent plasma. On the other hand, studies have revealed that medicinal plants such as garlic, among others, showed efficiency in modulating proteins with a view to preventing viral replication and improving immunity against COVID-19. So far, there are no drugs that are completely safe and have been shown to have activity against the new coronavirus (SARS-CoV-2). However, medicinal plants can contribute to the development of specific therapies against SARS-CoV-2 in a safe and effective way.


Em dezembro de 2019, um novo coronavírus originário da cidade de Wuhan, na China, iniciou uma epidemia que levou muitos países ao caos e ao desespero. O SARS-CoV-2, conforme identificado, deu origem à síndrome respiratória aguda grave chamada COVID-19. Sua transmissão acontece através de gotículas de saliva, mãos ou superfícies contaminadas. Desde sua descoberta, o COVID-19 levou muitos à morte, por isso, pesquisadores de todo o mundo uniram esforços para desenvolver estratégias para conter o vírus. Nesta corrida, medicamentos como Cloroquina e Hidroxicloroquina tornaram-se opções possíveis por apresentarem efeito antiviral, porém, estudos contestam sua eficiência, gerando incertezas. Portanto, outras alternativas têm sido investigadas nesse contexto, e o estudo de plantas medicinais tem sido alvo de pesquisas para o tratamento da COVID- 19 em busca de produtos naturais bioativos que possam exercer ação antiviral. O estudo teve como objetivo analisar a literatura publicada sobre COVID-19 (SARS-CoV-2) e sua relação com plantas medicinais. Levantamento bibliográfico. Até o momento, não foi encontrado nenhum tratamento específico contra a doença, apenas de suporte, com medicamentos que visam melhorar o sistema imunológico do indivíduo e garantir que o vírus não se replique, por exemplo, há opções como cloroquina, hidroxicloroquina, remdesivir e convalescença plasma. Por outro lado, estudos revelaram que plantas medicinais como o alho, entre outras, mostraram eficiência na modulação de proteínas visando prevenir a replicação viral e melhorar a imunidade contra a COVID-19. Até o momento, não existem medicamentos completamente seguros e que tenham demonstrado atividade contra o novo coronavírus (SARS-CoV-2). No entanto, as plantas medicinais podem contribuir para o desenvolvimento de terapias específicas contra o SARS-CoV-2 de forma segura e eficaz.


En diciembre de 2019, un nuevo coronavirus originario de la ciudad de Wuhan, en China, inició una epidemia que sumió a muchos países en el caos y la desesperación. El SARS-CoV- 2, tal y como fue identificado, dio lugar al síndrome respiratorio agudo severo denominado COVID-19. Su transmisión se produce a través de gotitas de saliva, de las manos o de superficies contaminadas. Desde su descubrimiento, el COVID-19 ha llevado a muchos a la muerte, por lo que investigadores de todo el mundo han aunado esfuerzos para desarrollar estrategias de contención del virus. En esta carrera, fármacos como la Cloroquina y la Hidroxicloroquina se han convertido en posibles opciones por mostrar un efecto antiviral, sin embargo, los estudios refutan su eficacia, generando incertidumbres. Por lo tanto, otras alternativas han sido investigadas en este contexto, y el estudio de las plantas medicinales ha sido el objetivo de la investigación para el tratamiento de COVID-19 en busca de productos naturales bioactivos que puedan ejercer una acción antiviral. El estudio tuvo como objetivo analizar la literatura publicada sobre el COVID-19 (SARS-CoV-2) y su relación con las plantas medicinales. Estudio bibliográfico. Hasta el momento, no se ha encontrado un tratamiento específico contra la enfermedad, sólo de soporte, con fármacos que buscan mejorar el sistema inmunológico del individuo y asegurar que el virus no se replique, por ejemplo, existen opciones como la cloroquina, hidroxicloroquina, remdesivir y plasma convaleciente. Por otro lado, estudios han revelado que plantas medicinales como el ajo, entre otras, mostraron eficacia en la modulación de proteínas con vistas a impedir la replicación viral y mejorar la inmunidad contra el COVID-19. Hasta el momento, no existen medicamentos que sean completamente seguros y que hayan demostrado tener actividad contra el nuevo coronavirus (SARS-CoV-2). Sin embargo, las plantas medicinales pueden contribuir al desarrollo de terapias específicas contra el SARS-CoV-2 de forma segura y eficaz.


Subject(s)
Plants, Medicinal/immunology , SARS-CoV-2/drug effects , Antiviral Agents/antagonists & inhibitors , Antiviral Agents/therapeutic use , Viral Vaccines/antagonists & inhibitors , Chloroquine/therapeutic use , Severe Acute Respiratory Syndrome/virology , Severe acute respiratory syndrome-related coronavirus , Pandemics/prevention & control , Garlic/immunology , COVID-19/epidemiology , Hydroxychloroquine/therapeutic use
13.
Actual. SIDA. infectol ; 30(109): 30-37, 20220000. graf
Article in Spanish | LILACS, BINACIS | ID: biblio-1392512

ABSTRACT

Introducción: La infección por VIH continúa siendo un problema de salud pública a nivel mundial. Las restricciones tomadas durante la pandemia por COVID-19 podrían afectar el alcance de las metas 95-95-95 propuestas por ONUSIDA. El objetivo de este trabajo fue determinar el impacto de la pandemia por COVID-19 en la realización de pruebas rápidas de VIH en un hospital general de agudos.Métodos: Análisis retrospectivo de los datos de pacientes mayores de 16 años, de ambos sexos, que se realizaron una prueba rápida de VIH durante la pandemia por COVID-19 vs. el período previo.Resultados: De 611 tests, 473 (77,4%) corresponden al período prepandémico y 138 (22,6%) al pandémico. La mediana de edad (rango intercuartílico) fue 32 años (24-40); sexo masculino 386 (63,2%), sin diferencias significativas. Durante el período prepandémico los motivos de testeo fueron control de salud 47,6% (n=225) y situaciones de riesgo/síntomas 52,4% (n=248), mientras que en el período pandémico fueron control de salud 27,5% (n=38) y situaciones de riesgo/síntomas 72,5% (n=100) respectivamente, p=0.0001. Tests positivos: 5,7% (n=27) vs. 8,7% (n=12), p=0.28. Las medianas de recuento de linfocitos T CD4+ y carga viral fueron: 327 cel/uL (135-718) y 66300 copias/mL (5260-192000), sin diferencias significativas.Conclusiones: La cantidad de testeos realizados durante la pandemia corresponde a un tercio de los realizados durante el período previo, con un descenso en aquellos motivados por controles de salud, evidenciando el impacto de la pandemia en el diagnóstico de VIH


INTRODUCTION: HIV infection remains as a public health worldwide problem. The restrictions taken during the COVID-19 pandemic could have affected the scope of the 95-95-95 goals proposed by UNAIDS. The aim of this work is to determine the impact of the COVID-19 pandemic on the performance of rapid HIV tests in an Acute General Hospital.METHODS: Retrospective analysis of data from patients over 16 years old, of both sexes, who underwent a rapid HIV test during the COVID-19 pandemic vs. the previous period.RESULTS: Of 611 tests, 473 (77.4%) correspond to the pre-pandemic period and 138 (22.6%) to the pandemic. The median age (interquartile range) was 32 years old (24-40); male sex 386 (63.2%), without significant differences. During the pre-pandemic vs pandemic period, the reasons for testing were: health control 47.6% (n=225) and risk situations/symptoms 52.4% (n=248), vs 27.5% (n= 38) and 72.5% (n=100) respectively, p=0.0001. Positive tests: 5.7% (n=27) vs 8.7% (n=12), p=0.28. The median CD4+ T lymphocyte count and viral load were: 327 cells/uL (135-718) and 66,300 copies/mL (5,260-192,000), with no significant differences.CONCLUSIONS: The number of tests carried out during the pandemic equals to a third of those performed during the previous period, with a decrease in those motivated by health controls; evidencing the impact of the pandemic on the diagnosis of HIV


Subject(s)
Humans , Adult , Middle Aged , Aged , Retrospective Studies , Early Diagnosis , Pandemics/prevention & control , HIV Testing , COVID-19/prevention & control
14.
Rev. chil. infectol ; 39(3): 287-293, jun. 2022.
Article in Spanish | LILACS | ID: biblio-1407795

ABSTRACT

Resumen Desde la llegada de la pandemia por COVID-19, se ha descrito un sinnúmero de consecuencias respecto a la infección por VIH en Chile, tanto en su diagnóstico como en su prevención, principalmente manifestadas en el descenso de la realización de exámenes serológicos, la interrupción de la atención, el retraso en el inicio de la terapia antirretroviral y la falta de acceso a métodos preventivos. A ello, se le suma el deterioro en algunas condiciones relacionadas con aspectos sociales y sobre salud mental. Todo esto implica, entre otras consecuencias, un probable empeoramiento en la situación epidemiológica de la infección por VIH en Chile. En el presente artículo, se revisarán algunos de los impactos señalados y se plantean algunos desafíos, para el enfrentamiento de esta problemática.


Abstract Since the arrival of the COVID-19 pandemic, countless consequences have been described regarding HIV infection in Chile, both in its diagnosis and prevention, mainly manifested in the decrease in serological tests, the interruption of care, the delay in starting antiretroviral therapy, and the lack of access to preventive methods. Added to this is the deterioration in some conditions related to social aspects and mental health. All this implies, among other consequences, a probable worsening in the epidemiological situation of HIV infection in Chile. Some of the designated impacts are reviewed in this article, and some challenges are raised to confront this problem.


Subject(s)
Humans , HIV Infections/diagnosis , HIV Infections/drug therapy , HIV Infections/epidemiology , COVID-19 , Chile/epidemiology , Pandemics/prevention & control
15.
Medwave ; 22(5): e8741, jun.-2022.
Article in English, Spanish | LILACS | ID: biblio-1378544

ABSTRACT

En marzo 2020 se despliega la primera versión de EPIVIGILA en un ambiente productivo, plataforma de integración tecnológica de vigilancia epidemiológica nacional para enfermedades de notificación obligatoria (a pocos días del caso 1 de COVID- 19 local). Anteriormente, Chile usaba un proceso manual que probablemente hubiese fracasado ante un volumen máximo superior a 38 000 notificaciones diarias, en un país con 18 millones de habitantes, de geografía larga y angosta y gobernanza centralizada. El objetivo del trabajo es relevar la importancia que tiene en el manejo de la pandemia el sistema nacional de vigilancia electrónico EPIVIGILA. La principal fortaleza del sistema es su capacidad de adaptación a las necesidades de información fidedigna, precisa, oportuna y en tiempo real. EPIVIGILA fue capaz de incluir, en el curso de las circunstancias, distintos flujos, actores, datos y funcionalidades con altas expectativas de exactitud. Ello permitió que las autoridades pudieran evaluar el impacto de las medidas implementadas para el manejo y control de la pandemia. Su versatilidad posiciona a esta plataforma entre las pocas en el mundo que opera datos nacionales en una pandemia con un alto nivel de granularidad en un único sistema. En Chile, EPIVIGILA es la principal fuente de información para los reportes diarios, informes epidemiológicos y datos publicados en sitios web gubernamentales sobre COVID- 19. Así, el uso de sistemas electrónicos muestran ser un soporte fundamental para la salud pública, porque el registro y procesamiento de los datos genera información clara, confiable y oportuna, contribuyendo a que las autoridades puedan tomar decisiones orientadas a disminuir la propagación de enfermedades transmisibles, evitar muertes y mejorar la calidad de vida de la población.


In March 2020, the first version of EPIVIGILA was deployed in a productive environment a few days after the first local case of COVID- 19. This system is a technological integration plat-form for national epidemiological surveillance of notifiable diseases. Previously, Chile used a manual process that would probably have failed with a peak volume of more than 38 000 daily notifications; in a country with 18 million inhabitants, long and narrow geography, and centralized governance. This work highlights the importance of the national electronic surveillance system ­ EPIVIGILA ­ in managing the pandemic. The system's main strength is its ability to adapt to the needs of reliable, precise, timely, and real- time information. EPIVIGILA was able to include, under the circumstances, different flows, actors, data, and functionalities with high expectations of accuracy. This valuable information allowed the authorities to assess the impact of the measures to manage and control the pandemic. Its versatility positions this platform among the few globally that operates national data with a high level of granularity in a single system through a pandemic. In Chile, EPIVIGILA is the primary source of information for daily reports, epidemiological reports, and data published on government websites about COVID- 19. Thus, electronic systems prove fundamental for public health because the recording and processing of data generate clear, reliable, and timely information, helping authorities make decisions to reduce the spread of infectious diseases, prevent deaths, and improve the population's quality of life.


Subject(s)
Humans , COVID-19/epidemiology , Quality of Life , Public Health , Pandemics/prevention & control , SARS-CoV-2
16.
Rev. méd. Maule ; 37(1): 93-104, jun. 2022.
Article in Spanish | LILACS | ID: biblio-1397752

ABSTRACT

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus belonging to the beta coronavirus family, it is the cause of the COVID-19 disease and the pandemic that has revolutionized and challenged the medical research profession and health systems around the world. With the first coronavirus SARS-CoV, the important role of the angiotensin 2-converting enzyme (ACE2) in the pathophysiology of the disease caused by the virus was discovered, a discovery that would lay the foundations on which research on the new coronavirus is based. The virus is capable of producing disease with a wide spectrum of clinical presentation, from asymptomatic patients to patients with severe acute respiratory distress syndrome (ARDS) requiring admission to intensive care units (ICU). The most commonly described symptoms are fever, cough, myalgia, and dyspnea. However, and with advances in the knowledge of SARS-CoV-2 infection, it has been discovered that gastrointestinal (GI) symptoms are frequent and have been associated with severe disease. Viral RNA has been found in feces, urine, blood, and other fluids, which could mean that there are other routes of infection that have not been considered a threat by the medical community until now. In this article, an updated bibliographic review of this topic is presented, with articles selected from the PubMed platform.


Subject(s)
Humans , Pancreatitis , Pandemics/prevention & control , COVID-19 , COVID-19/complications , Acute Disease , Gastrointestinal Tract , Kobuvirus , Feces , Fever/etiology , SARS-CoV-2
17.
Educ. med. super ; 36(1)mar. 2022. ilus
Article in Spanish | LILACS, CUMED | ID: biblio-1404524

ABSTRACT

Introducción: La pandemia COVID-19, causada por el virus SARS-CoV-2, y su exponencial crecimiento y migración a todos los continentes del globo terráqueo, provocaron una parálisis en el proceso de enseñanza-aprendizaje en las instituciones que no contaban con infraestructura en línea para el desarrollo de las actividades docentes de manera virtual. Objetivo: Exponer los retos, las soluciones y los aprendizajes que formaron parte del proceso para preservar las discusiones de casos clínicos en grupos pequeños de estudiantes durante las fases de cuarentena obligatoria de la pandemia en Sudáfrica. Métodos: Se aplicaron las fases de la investigación-acción adaptadas a las prácticas educacionales. En su ejecución participaron los 103 estudiantes del segundo año del grado de bachiller en Medicina y Cirugía, y sus 10 tutores. El módulo de Neurociencias fue el contexto educativo en el período comprendido entre abril y julio de 2020. Resultados: Se crearon chats de comunicación entre los actores del proceso. El módulo se prolongó en duración, y flexibilizó la frecuencia y el horario de las tutorías. Se redujo el número de secciones a develar de los casos y en cada una se introdujeron tareas que guiaron a aplicar contenidos derivados de los objetivos de aprendizaje. Se escogió la aplicación WhatsApp como la plataforma donde se realizarían las sesiones de tutoría. Conclusiones: El desplazamiento del aprendizaje colaborativo de las tutorías a la aplicación WhatsApp convirtió a esta plataforma en un aula virtual accesible en áreas de pobre conectividad. Los reajustes en la extensión y duración de los casos, y las nuevas tareas en sus secciones, se adaptaron a un proceso de asimilación más lento y con más opciones de mediación. Múltiples y variados resultaron los aprendizajes para los actores del proceso; vale destacar el humano y el tecnológico.


ABSTRACT Introduction: The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, as well as its exponential growth and migration to all continents of the globe, caused a paralysis in the teaching-learning process in institutions that did not have online infrastructure for the development of virtual teaching activities. Objective: To expose the challenges, solutions and learning that were part of the process for preserving clinical case discussions in small groups of students during the mandatory quarantine phases of the pandemic in South Africa. Methods: Action research phases adapted to educational practices were applied. All 103 second-year Bachelor of Medicine and Surgery students and their ten tutors participated in its execution. The Neurosciences module was the educational context in the period from April to July 2020. Results: Communication chats were created between the actors of the process. The module was extended in length, and the frequency and schedule of tutoring sessions was made more flexible. The number of sections to be unveiled from the cases was reduced; each section included guiding tasks for applying contents derived from the learning objectives. The WhatsApp application was chosen as the platform where the tutoring sessions would take place. Conclusions: The shift of collaborative learning from tutorials to the WhatsApp application turned this platform into a virtual classroom accessible in areas of poor connectivity. The length readjustments in the cases, as well as the new tasks in their sections, were adapted to a slower assimilation process and with more mediation options. There were multiple and varied learning experiences for the actors in the process; it is worth highlighting the human and technological aspects.


Subject(s)
Humans , Cell Phone , Internet Access , Learning , Education, Distance/methods , Pandemics/prevention & control , Mentoring/methods
19.
Ciênc. Saúde Colet. (Impr.) ; 27(3): 969-978, mar. 2022. tab, graf
Article in Portuguese | LILACS | ID: biblio-1364705

ABSTRACT

Resumo O objetivo do estudo foi avaliar o impacto da pandemia de COVID-19 nos valores de vacinação para as imunizações voltadas a indivíduos com menos de um ano de vida no Brasil. Analisou-se os valores de cobertura vacinal, em território nacional, de dez vacinas presentes no calendário do Programa Nacional de Imunizações (PNI) durante os últimos oito anos (2013-2020). Esse é um estudo ecológico e todos os dados foram extraídos do PNI. Comparativamente aos anos prévios, em 2020 registrou-se o menor valor de cobertura vacinal da média do conjunto das vacinas estudadas, 75,07%, enquanto em 2019 esse mesmo índice ficou em 84,44%, resultando em uma queda de 11,10% entre esses dois períodos. Além disso, no ano da pandemia, das dez vacinas analisadas, nove registraram o seu menor valor histórico de cobertura, todas estando a no mínimo 14 pontos percentuais abaixo da meta do Ministério da Saúde. Embora já houvesse uma tendência de queda na cobertura vacinal, por diversos motivos, o presente estudo demonstra que os valores registrados em 2020 foram significativamente menores, fenômeno também registrado em outros países. Portanto, mesmo não conseguindo afirmar que a pandemia de COVID-19 e as medidas de distanciamento sejam as causas da queda dos valores de imunização, podemos inferir que há uma associação.


Abstract This study aimed to evaluate the impact of the COVID-19 pandemic on the vaccination numbers for immunization geared toward individuals under 12 months of age in Brazil. This study analyzed the numbers of the nationwide vaccination coverage of ten vaccines present in the calendar from the National Immunization Program (NIP) over the past eight years (2013-2020). This is an ecological study, and all data were taken from the NIP. In comparison to the previous years, 2020 recorded the lowest figures of vaccination coverage (VC) of the average of the group of studied vaccines - 79.07% - while in 2019, this same index was 84.44%, resulting in a drop of 11.10% between these two periods. Moreover, during the year of the pandemic, of the ten analyzed vaccines, nine recorded their lowest historical VC figures, all of which were at least 14 percentage points below the goals set by the Brazilian Ministry of Health (MS, in Portuguese). Although there had already been a tendency toward a decline in VC, for various reasons, the present study illustrates that the numbers recorded in 2020 were significantly lower, a phenomenon also reported in other countries. Therefore, although it is impossible to affirm that the COVID-19 pandemic and its distancing measures are the causes for the drop in the immunization numbers, it can be inferred that there is indeed an association.


Subject(s)
Humans , Child , Pandemics/prevention & control , COVID-19/prevention & control , COVID-19/epidemiology , Vaccination , Immunization Programs , Vaccination Coverage
20.
São Paulo med. j ; 140(2): 305-309, Jan.-Feb. 2022. graf
Article in English | LILACS | ID: biblio-1366034

ABSTRACT

Abstract BACKGROUND: Meningitis is listed as one of the diseases requiring compulsory notification in Brazil. It can affect all age groups and also has no seasonality. Cases can be recorded in all months of the year and in all states of Brazil. Despite its importance, the obligation of immediate notification may have been compromised by the coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVE: To analyze the immediate impact of the COVID-19 pandemic on compulsory notifications of meningitis in Brazil and its states during the first wave of the pandemic. DESIGN AND SETTING: This was an ecological study involving all confirmed cases of meningitis in Brazil, in its regions and in its states. METHODS: Data for the months from 2015 to 2020 were obtained from the database of the Notifiable Diseases Information System (Sistema de Informação de Agravos de Notificação, SINAN), in the Department of Informatics of the National Health System (Departamento de Informática do Sistema Único de Saúde, DATASUS). The P-score was used to obtain the percentage change in the numbers of cases reported in 2020. RESULTS: A 45.7% reduction in notifications of meningitis in Brazil was observed. Regarding the regions and the states, with the exception of Roraima, all of them showed a negative P-score, with decreasing curves each month. CONCLUSION: The pandemic caused a negative impact on meningitis notifications in Brazil.


Subject(s)
COVID-19/epidemiology , Meningitis/epidemiology , Brazil/epidemiology , Disease Notification , Pandemics/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL